EIP
IBB icon

Ellis Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History

Ellis Investment Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Sell
3,202
-53
-2% -$9.11K 0.09% 155
2026
Q1 		$550K Buy
3,255
+59
+2% +$10.1K 0.1% 153
2025
Q4 		$540K Sell
3,196
-44
-1% -$7.15K 0.09% 154
2025
Q3 		$468K Sell
3,240
-277
-8% -$37.8K 0.08% 158
2025
Q2 		$445K Buy
3,517
+13
+0.4% +$1.6K 0.09% 158
2025
Q1 		$448K Sell
3,504
-167
-5% -$22.6K 0.09% 146
2024
Q4 		$485K Sell
3,671
-4
-0.1% -$562 0.1% 141
2024
Q3 		$535K Sell
3,675
-486
-12% -$70.3K 0.1% 140
2024
Q2 		$571K Sell
4,161
-633
-13% -$84.5K 0.12% 131
2024
Q1 		$658K Sell
4,794
-1,032
-18% -$141K 0.14% 120
2023
Q4 		$791K Sell
5,826
-942
-14% -$115K 0.18% 95
2023
Q3 		$828K Sell
6,768
-35
-0.5% -$4.45K 0.21% 95
2023
Q2 		$864K Sell
6,803
-160
-2% -$20.8K 0.21% 92
2023
Q1 		$899K Sell
6,963
-506
-7% -$66.2K 0.23% 90
2022
Q4 		$981K Sell
7,469
-1,237
-14% -$160K 0.27% 85
2022
Q3 		$1.02M Sell
8,706
-701
-7% -$87K 0.28% 77
2022
Q2 		$1.11M Sell
9,407
-1,267
-12% -$150K 0.3% 73
2022
Q1 		$1.39M Sell
10,674
-12,698
-54% -$1.65M 0.33% 65
2021
Q4 		$3.57M Sell
23,372
-12
-0.1% -$1.86K 0.82% 30
2021
Q3 		$3.78M Buy
23,384
+169
+0.7% +$28.4K 0.96% 23
2021
Q2 		$3.8M Sell
23,215
-2,328
-9% -$359K 0.97% 22
2021
Q1 		$3.85M Buy
25,543
+1,553
+6% +$247K 1.07% 20
2020
Q4 		$3.63M Buy
23,990
+3,972
+20% +$568K 1.1% 19
2020
Q3 		$2.71M Buy
20,018
+929
+5% +$126K 0.95% 25
2020
Q2 		$2.62M Sell
19,089
-1,673
-8% -$213K 0.98% 23
2020
Q1 		$2.15M Buy
20,762
+5,434
+35% +$626K 1.02% 23
2019
Q4 		$1.84M Buy
15,328
+387
+3% +$43.2K 0.61% 35
2019
Q3 		$1.46M Sell
14,941
-260
-2% -$27.2K 0.53% 38
2019
Q2 		$1.67M Sell
15,201
-258
-2% -$27.4K 0.62% 32
2019
Q1 		$1.73M Sell
15,459
-1,022
-6% -$112K 0.7% 34
2018
Q4 		$1.62M Buy
+16,481
New +$1.75M 0.74% 32

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Ellis Investment Partners's IBB Position: Q2 2026 in Review

Ellis Investment Partners reduced its iShares Biotechnology ETF (IBB) stake by 1.6% in Q2 2026, selling an estimated $9.11K and leaving 3,202 shares worth $609K. The position accounts for 0.09% of the portfolio, ranked #155.

Ellis Investment Partners first reported a position in IBB in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.85M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Ellis Investment Partners held 3,202 shares of iShares Biotechnology ETF worth $609K as of Q2 2026.
  • Ellis Investment Partners sold 53 iShares Biotechnology ETF shares in Q2 2026, an estimated $9.11K.
  • iShares Biotechnology ETF made up 0.09% of Ellis Investment Partners's portfolio in Q2 2026, its #155 holding.
  • Ellis Investment Partners first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 31 quarters since.
  • Ellis Investment Partners's iShares Biotechnology ETF position peaked at $3.85M in Q1 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.